Armelle Vinceneux

Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)

Loïc Lebellec, Bruno Chauffert, Jean‐Yves Blay et al. · European Journal of Cancer · 2017 · 56 citations

Medicine, Oncology, Surgery +13

5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study

Anne Ploquin, B. Pistilli, Emmanuelle Tresch et al. · European Journal of Cancer · 2018 · 38 citations

Medicine, Obstetrics, Oncology +15

Ductal adenocarcinoma of the prostate: Clinical and biological profiles

Armelle Vinceneux, F. Bruyère, O. Haillot et al. · The Prostate · 2017 · 33 citations

Medicine, Oncology, Pathology +17

Safety, pharmacokinetics, efficacy, and preliminary biomarker data of first-in-class BI 765063, a selective SIRPα inhibitor: Results of monotherapy dose escalation in phase 1 study in patients with advanced solid tumors.

Stéphane Champiat, Philippe A. Cassier, Nuria Kotecki et al. · Journal of Clinical Oncology · 2021 · 27 citations

Medicine, Oncology, Pharmacotherapy +16

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

Mark N. Stein, Armelle Vinceneux, Debbie Robbrecht et al. · Journal of Clinical Oncology · 2025 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17